Sonja Kotnik

Title: Sonja Kotnik: Innovator in Pharmaceutical Chemistry

Introduction

Sonja Kotnik is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel inclusion complexes for clavulanic acid. With a total of 4 patents, her work has implications for the treatment of infectious diseases.

Latest Patents

Kotnik's latest patents focus on the preparation of alkali clavulanate from crude clavulanic acid. This process involves extracting clavulanic acid with an ethyl acetate solution of a hydrophobic beta-cyclodextrin derivative. The resulting inclusion complexes are isolated and purified, leading to the production of alkali clavulanate. Additionally, her patents describe new inclusion complexes of clavulanic acid with both hydrophilic and hydrophobic beta-cyclodextrin derivatives. These innovations are valuable for creating galenic forms with immediate and sustained action, especially in combination with amoxicillin trihydrate.

Career Highlights

Throughout her career, Sonja Kotnik has worked with notable companies such as Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., and Lek, Tovarna, Farmacevtskih in Kemicnih Izdelkov. Her expertise in pharmaceutical development has positioned her as a key figure in her field.

Collaborations

Kotnik has collaborated with esteemed colleagues, including Janko Zmitek and Darja Fercej-Temeljotov. These partnerships have further enhanced her research and development efforts in pharmaceutical innovations.

Conclusion

Sonja Kotnik's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the development of effective treatments for infectious diseases.